Home › NDC Lookup › RxCUI directory › RxCUI 2679070

Aprocitentan 12.5 MG Oral Tablet [Tryvio] — RxCUI 2679070

RxNorm drug concept · Semantic branded drug
RxCUI 2679070 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2679070
Official nameAprocitentan 12.5 MG Oral Tablet [Tryvio]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTryvio 12.5 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aprocitentan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tryvio is used to help lower blood pressure that hasn't been brought under control with other medications. It's always added on top of your existing blood pressure treatment — it's...
  • What exactly is Tryvio for — and will it replace my other blood pressure medications?
  • Take Tryvio once a day, at whatever time works best for your routine. You can take it with or without food — it doesn't matter. Swallow the tablet whole. If you forget a dose, just...
  • The most common side effects are swelling or fluid buildup (especially in your legs or ankles) and anemia, which can make you feel tired or weak. These are worth mentioning to your...
📖 Read our full Aprocitentan guide →

🕸️ Concept Web — How Aprocitentan 12.5 MG Oral Tablet [Tryvio] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aprocitentan 12.5 MG Oral Tablet [Tryvio] RxCUI 2679070

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aprocitentan 2679059
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tryvio 2679065
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aprocitentan Oral Tablet 2679063
    • Aprocitentan Oral Product 2679061
    • Aprocitentan Pill 2679062
    • Aprocitentan Oral Tablet [Tryvio] 2679069
    • Tryvio Oral Product 2679067
    • Tryvio Pill 2679068
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aprocitentan 12.5 MG Oral Tablet SCD · 2679064
  • Aprocitentan 12.5 MG SCDC · 2679060
  • Aprocitentan Oral Tablet SCDF · 2679063
  • Aprocitentan Oral Product SCDG · 2679061
  • Aprocitentan Pill SCDG · 2679062

Brand-Name Concepts

  • Aprocitentan 12.5 MG [Tryvio] SBDC · 2679066
  • Aprocitentan Oral Tablet [Tryvio] SBDF · 2679069
  • Tryvio Oral Product SBDG · 2679067
  • Tryvio Pill SBDG · 2679068
  • Tryvio BN · 2679065

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2679070 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80491-8012-03 1 BOTTLE in 1 CARTON (80491-8012-3) / 30 TABLET, FILM COATE... TRYVIO Idorsia Pharmaceuticals Ltd 2024-10-01
80491-8012-08 1 BLISTER PACK in 1 CARTON (80491-8012-8) / 10 TABLET, FILM... TRYVIO Idorsia Pharmaceuticals Ltd 2024-03-20
Observed labelers: Idorsia Pharmaceuticals Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.